XML 71 R48.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY DEFERRED REVENUE (Details) - USD ($)
 12 Months Ended
Apr. 21, 2022
Dec. 31, 2022
Dec. 31, 2021
RELATED PARTY LIABILITY      
Revenue recognized   $ 9,013,544 $ 1,241,710
Related party deferred revenue   2,500,000  
Wilson Wolf Manufacturing Corporation | Binding Services Agreement      
RELATED PARTY LIABILITY      
Cash payment from related party $ 8,000,000.0    
Advance received for non-exclusive training of Wilson Wolf to make, use, and sell Marker's cell culture non-proprietary media formulation 2,000,000.0    
Advance received for non-exclusive training of Wilson Wolf to replicate Marker's quality management system inclusive of all underlying documents 1,000,000.0    
Advance received for non-exclusive training of Wilson Wolf to replicate Marker's cGMP-compliant, linearly scalable, G-Rex based T-cell manufacturing process 2,000,000.0    
Advance received under the hired to invent doctrine for Marker to train Wilson Wolf on its expertise in the optimization of T-cell therapy manufacturing processes $ 3,000,000.0    
Period for completion of optimization work under the direction of Wilson Wolf which Marker will make good faith efforts from the agreement date 18 months    
Additional amount agreed to received from Wilson Wolf if the Work Direction is completed within one year from the onset of the agreement $ 1,000,000.0    
Threshold minimum combined voting power of the surviving entity or parent corporation of the surviving entity considered (in percent) 50.00%    
Revenue recognized   5,500,000  
Related party deferred revenue   2,500,000  
Related party service revenue      
RELATED PARTY LIABILITY      
Revenue recognized   $ 5,500,000